Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Roose

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Psychiatry|July 1, 1989
Depression, heart disease, and tricyclic antidepressantsS P Roose, A H Glassman, G W Dalack
Journal of Medical Education|September 1, 1980
An experience with patient role-playing in psychiatric educationS G Siris, J P Docherty, S P Roose
JAMA|May 26, 1993
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsideredA H Glassman, S P Roose, J T Bigger
Clinical Neuropharmacology|January 1, 1992
Antidepressants in the cardiac patientA H Glassman, S P Roose, B T Walsh
The American Journal of Psychiatry|December 1, 1994
Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholiaS P Roose, A H Glassman, E Attia, et al.
Journal of Clinical Psychopharmacology|June 1, 1984
Imipramine-induced inappropriate ADH secretionB Liskin, B T Walsh, S P Roose, et al.
The Journal of Clinical Psychiatry|July 24, 2001
Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trialS N Seidman, E Spatz, C Rizzo, et al.
The Journal of Clinical Psychiatry|April 1, 1988
'Spontaneous' hypertensive episodes with monoamine oxidase inhibitorsB Fallon, B Foote, B T Walsh, et al.
Neuropsychobiology|January 1, 1982
Reversible loss of nocturnal penile tumescence during depression: a preliminary reportS P Roose, A H Glassman, B T Walsh, et al.
The American Journal of Psychiatry|March 1, 1986
Tricyclic nonresponders: phenomenology and treatmentS P Roose, A H Glassman, B T Walsh, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Psychiatry|July 1, 1989
Depression, heart disease, and tricyclic antidepressantsS P Roose, A H Glassman, G W Dalack
Journal of Medical Education|September 1, 1980
An experience with patient role-playing in psychiatric educationS G Siris, J P Docherty, S P Roose
JAMA|May 26, 1993
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsideredA H Glassman, S P Roose, J T Bigger
Clinical Neuropharmacology|January 1, 1992
Antidepressants in the cardiac patientA H Glassman, S P Roose, B T Walsh
The American Journal of Psychiatry|December 1, 1994
Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholiaS P Roose, A H Glassman, E Attia, et al.
Journal of Clinical Psychopharmacology|June 1, 1984
Imipramine-induced inappropriate ADH secretionB Liskin, B T Walsh, S P Roose, et al.
The Journal of Clinical Psychiatry|July 24, 2001
Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trialS N Seidman, E Spatz, C Rizzo, et al.
The Journal of Clinical Psychiatry|April 1, 1988
'Spontaneous' hypertensive episodes with monoamine oxidase inhibitorsB Fallon, B Foote, B T Walsh, et al.
Neuropsychobiology|January 1, 1982
Reversible loss of nocturnal penile tumescence during depression: a preliminary reportS P Roose, A H Glassman, B T Walsh, et al.
The American Journal of Psychiatry|March 1, 1986
Tricyclic nonresponders: phenomenology and treatmentS P Roose, A H Glassman, B T Walsh, et al.
Pageof 11